c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral

T Hayashi1, K Sakai, C Sasaki

  • 1Department of Neurology, Okayama University Medical School, 2-5-1 Shikata-machi, 700-8558, Okayama, Japan. thayashi@cc.okayama-u.ac.jp

Neuroscience Letters
|April 25, 2000
PubMed

Insights

c-Jun N-terminal kinase-1 (JNK-1) activation is key in ischemic brain injury. JNK-1 and its phosphorylated form increase after stroke, while JNK interacting protein-1 (JIP-1) rises later, suggesting a potentially ineffective survival response.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Ischemic brain injury involves c-Jun response, activated by c-Jun N-terminal kinase-1 (JNK-1).
  • JNK-1 activity is regulated by phosphorylation and nuclear translocation, with JNK interacting protein-1 (JIP-1) inhibiting its activation.
  • Understanding these molecular events is crucial for developing stroke therapies.

Purpose of the Study:

  • To investigate the temporal changes in JNK-1, phospho-JNK, and JIP-1 immunoreactivity in a rat model of transient middle cerebral artery (MCA) occlusion.
  • To elucidate the role of JIP-1 in the context of JNK-1 activation following ischemic stroke.

Main Methods:

  • Transient middle cerebral artery (MCA) occlusion model in rats.
  • Immunohistochemical analysis of JNK-1, phospho-JNK, and JIP-1 expression at various time points post-reperfusion.
  • Assessment of protein localization within neuronal compartments (cytoplasm and nucleus).

Main Results:

  • JNK-1 and phospho-JNK immunoreactivity increased significantly from 8 hours to 72 hours post-reperfusion, with nuclear and cytoplasmic staining observed.
  • JIP-1 immunoreactivity remained negative until 8 hours, becoming positive in cortical neurons at 24 and 72 hours post-reperfusion.
  • JIP-1 induction lagged behind JNK-1 activation, suggesting a delayed and potentially insufficient protective response.

Conclusions:

  • The delayed induction of JIP-1 after JNK-1 activation in ischemic stroke may represent a futile attempt by neurons to survive.
  • Targeting JNK-1 activation could offer a novel therapeutic strategy for treating stroke.
  • Further research into the precise mechanisms of JNK-1 regulation and JIP-1 interaction is warranted.